Kommentar zu: Klonale Hämatopoese bei Blutspendern

• Literatur

• 1 Khoury JD, Solary E, Abla O. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 2022; 36: 1703-1719
• 2 Jaiswal S, Fontanillas P, Flannick J. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371: 2488-2498
• 3 Genovese G, Kahler AK, Handsaker RE. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 2014; 371: 2477-2487
• 4 Hecker JS, Hartmann L, Riviere J. et al. CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease. Blood 2021; 138: 1727-32
• 5 Karpova D, Huerga Encabo HD, Donato E. et al. Clonal Hematopoiesis Landscape in Frequent Blood Donors. Blood. 2025
• 6 Florez MA, Tran BT, Wathan TK. et al. Clonal hematopoiesis: Mutation-specific adaptation to environmental change. Cell Stem Cell 2022; 29: 882-904
• 7 van Zeventer IA, de Graaf AO, Wouters HJCM. et al. Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals. Blood 2020; 135: 1161-1170